Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ana Pilar Gonzalez-Rodriguez (Ana P González-Rodríguez, Ana P Gonzalez-Rodriguez)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Cancers

Journal of clinical medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana Pilar Gonzalez-Rodriguez, Alejandra Martínez-Pérez, Juan P Rodrigo, Juana María García-Pedrero, Segundo González
Chemo-Immunotherapy: A New Trend in Cancer Treatment. Cancers 15 (11) (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, Ibai Goicoechea, Cristina Perez, Juan-José Garcés, Cirino Botta, María-José Calasanz, Norma C Gutierrez, Maria-Luisa Martin-Ramos, Albert Oriol, Rafael Rios-Tamayo, Miguel-Teodoro Hernandez, Rafael Martinez-Martinez, Joan Bargay, Felipe De Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Adrian Mosquera-Orgueira, Marta-Sonia Gonzalez-Perez, Joaquin Martinez-Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos, Jesus F San-Miguel, Bruno Paiva
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana Pilar Gonzalez-Rodriguez, Ángel R Payer, Esther González-García, Alejandro López-Soto, Segundo González
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia. Cancers 13 (9) (2021)
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana Pilar Gonzalez-Rodriguez, Ángel R Payer, Esther González-García, Alejandro López-Soto, Segundo González
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia. Cancers 13 (8) (2021)
Ana Pilar Gonzalez-Rodriguez, Angel R Payer, Juan J Menendez-Suarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Joud Zanabili, Ariana Fonseca, Ana Julia Gonzalez-Huerta, Pilar Palomo, Segundo González
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression. Journal of clinical medicine 9 (11) (2020)
Ana Pilar Gonzalez-Rodriguez, Mónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Segundo González
NK Cells in the Treatment of Hematological Malignancies. Journal of clinical medicine 8 (10) (2019)
Seila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, Ana Pilar Gonzalez-Rodriguez, Massimo Vitale, Segundo González
NK Cell-Based Immunotherapy in Cancer Metastasis. Cancers 11 (1) (2018)

Ana Pilar Gonzalez-Rodriguez.css-eqlu8i{font-size:small;padding-left:4px;} (Ana P González-Rodríguez, Ana P Gonzalez-Rodriguez)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Pilar Gonzalez-Rodriguez (Ana P González-Rodríguez, Ana P Gonzalez-Rodriguez)